- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06753123
Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers (Aim 2)
May 28, 2026 updated by: San Diego State University
Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers.
This study develops and tests a dynamic workplace-based depression intervention that is tailored to the specific social and behavioral needs of low-wage hospital service workers.
The intervention involves assessment of depression-related work impairment, work-focused cognitive behavioral therapy, work coaching, social needs screening and referral, and text message support for mood and physical activity.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Depression and physical inactivity are leading contributors to cardiometabolic diseases such as obesity, diabetes, and cardiovascular disease.
Low-wage workers, who comprise one third of all workers in the U.S. and are essential to many industries, are more likely to be physically inactive and to have cardiometabolic conditions and depression, yet the participants are half as likely as higher wage workers to utilize preventive care.
Targeted workplace initiatives have been successful in improving employee health, but low-wage workers are difficult to engage, in part due to a high burden of social disadvantage (e.g., food and housing insecurity, time and financial constraints).
There are few, if any, workplace interventions for depression that specifically target low-wage workers and the participants unique social risk factors.
This study was conceptualized using a planned adaptation approach that involves low-wage workers in the design of the intervention to increase engagement and feasibility.
The study will test an evidence-based 8-session telephone-delivered depression intervention for working adults, Be Well at Work, and critical adaptations for low-wage workers: assessment and referrals for social determinants of health (e.g., food and housing insecurity, financial stress), physical activity promotion, and personalized text message behavioral support.
The adapted intervention, Be Well at Work-PLUS, will be tested first in a single-arm open pilot (N=10) with exit interviews to refine the intervention content and delivery.
Later, a pilot randomized controlled trial comparing Be Well at Work-PLUS to a waitlist condition (N=60) will be conducted (separate ClinicalTrials.gov
study).
The primary objectives are to assess acceptability, feasibility, and preliminary clinical outcomes.
The primary preliminary clinical outcome is depression symptom severity, and secondary outcomes are physical activity, sleep quality, blood pressure, and BMI).
Study Type
Interventional
Enrollment (Estimated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jessica L McCurley, PhD, MPH
- Phone Number: 619-594-2132
- Email: jlmccurley@sdsu.edu
Study Locations
-
-
California
-
San Diego, California, United States, 92115
- Recruiting
- San Diego State University
-
Contact:
- Jessica L McCurley, PhD, MPH
- Phone Number: 619-594-2132
- Email: jlmccurley@sdsu.edu
-
Principal Investigator:
- Jessica L McCurley, PhD, MPH
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- part-time or full-time employment (at least 20 hours per week);
- ≥18 years old;
- employed in low-wage-earning jobs in the Environmental Services or Food & Nutrition Services Departments;
- presence of depression symptoms as measured by the Patient Health Questionnaire-9 item version; individuals who score ≥5 (indicating mild depression symptoms or higher) will be eligible;
- presence of impairment in work functioning, as measured by the Work Limitations Questionnaire; individuals who score ≥5% (indicating mild work productivity loss) will be eligible;
- possession of a cell phone with ability to receive text-messages;
- Fluent in either English or Spanish.
Exclusion Criteria:
- plan to leave Scripps employment in <6 months;
- severe mental illness or substance use condition (e.g., bipolar disorder, schizophrenia, active alcohol use disorder)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Single Arm: Open Pilot of Intervention
The intervention consists of assessment of depression and work impairment, work-focused cognitive behavioral therapy, work coaching, social needs screening and referral, and text message support for mood and physical activity.
|
This intervention is a remotely delivered workplace-based depression intervention that is tailored to the specific social and behavioral needs of low-wage hospital service workers.
The intervention involves assessment of depression-related work impairment, work-focused cognitive behavioral therapy, work coaching, social needs screening and referral, and text message support for mood and physical activity.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intervention Feasibility
Time Frame: From enrollment to end of treatment (approximately 4 months after enrollment).
|
Feasibility will be assessed by the number of intervention sessions completed.
The intervention will be considered feasible if the majority of participants complete 75% (6 of 8) or more phone sessions.
|
From enrollment to end of treatment (approximately 4 months after enrollment).
|
|
Acceptability
Time Frame: From enrollment to end of treatment (approximately 4 months after enrollment)
|
Acceptability will be assessed by the average of participants' ratings of intervention components on a 0-10 scale.
Participants will rate each counseling session independently and will rate text messages on a monthly basis.
The intervention will be considered acceptable if mean ratings are ≥ 7/10.
|
From enrollment to end of treatment (approximately 4 months after enrollment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression symptoms
Time Frame: From baseline through end of treatment (approximately 4 months after enrollment).
|
Depression symptoms will be measured with the Patient Health Questionnaire - 9 item version (range 0-27, higher = worse depression symtpoms)
|
From baseline through end of treatment (approximately 4 months after enrollment).
|
|
Work limitations
Time Frame: From baseline to end of treatment (approximately 4 months after enrollment)
|
Work limitations (range: 0-100%, higher = more limitation) will be measured by the Work Limitations Questionnaire.
|
From baseline to end of treatment (approximately 4 months after enrollment)
|
|
Perceived stress
Time Frame: From baseline to end of treatment (approximately 4 months after enrollment)
|
Perceived stress measured by the Perceived Stress Scale (range 0-40, higher = more perceived stress).
|
From baseline to end of treatment (approximately 4 months after enrollment)
|
|
Sleep quality
Time Frame: From baseline to end of treatment (approximately 4 months after enrollment)
|
Sleep quality and duration as measured by the Pittsburgh Sleep Quality Index (range: 0-21, higher scores indicate worse sleep quality).
|
From baseline to end of treatment (approximately 4 months after enrollment)
|
|
Physical activity - step count
Time Frame: From baseline to end of treatment (approximately 4 months after enrollment)
|
Weekly step count as measured by wrist-worn FitBit watch
|
From baseline to end of treatment (approximately 4 months after enrollment)
|
|
Body mass index (BMI)
Time Frame: From baseline to end of treatment (approximately 4 months after enrollment)
|
A weight-to-height ratio, calculated by dividing participant's weight in kilograms by height in meters squared.
|
From baseline to end of treatment (approximately 4 months after enrollment)
|
|
Blood pressure
Time Frame: From baseline to end of treatment (approximately 4 months after enrollment)
|
Resting systolic and diastolic blood pressures
|
From baseline to end of treatment (approximately 4 months after enrollment)
|
|
Physical activity - self report
Time Frame: From baseline to end of treatment (approximately 4 months after enrollment)
|
Self-reported physical activity using the International Physical Activity Questionnaire [low/medium/high activity; metabolic equivalents (METs) per week]
|
From baseline to end of treatment (approximately 4 months after enrollment)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jessica L McCurley, PhD, MPH, San Diego State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 28, 2026
Primary Completion (Estimated)
June 30, 2026
Study Completion (Estimated)
July 31, 2026
Study Registration Dates
First Submitted
December 18, 2024
First Submitted That Met QC Criteria
December 21, 2024
First Posted (Actual)
December 31, 2024
Study Record Updates
Last Update Posted (Actual)
June 1, 2026
Last Update Submitted That Met QC Criteria
May 28, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- HS-2024-0219
- K23HL157763 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
We do not plan to share data as this is an open pilot study with a very small number of participants (N=10), and it would be too easy to identify individuals.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on A workplace-based depression intervention for low-wage hospital workers
-
San Diego State UniversityNational Heart, Lung, and Blood Institute (NHLBI)Not yet recruitingDepression | Physical InactivityUnited States